News
Helima Croft, RBC global head of commodity strategy, joins 'Power Lunch' to discuss if the Saudis can help bring lower ...
Junior Madison Adam rushes for two touchdowns to help New Egypt advance to the semifinals of the Shore Conference Tournament.
Investing.com -- RBC Capital Markets downgraded Associated British Foods plc (LON: ABF) to "sector perform" from "outperform, ...
Thieves fled the scene in a silver grey SUV after robbing transit officers from a security company of money and a firearm on ...
Royal Bank of Canada’s decision to drop its sustainable finance commitment has sparked speculation that other major Canadian ...
Following the company’s most recent results, RBC Dominion Securities analyst James McGarragle is feeling more bullish about ...
The Mosaic Co. (NYSE:MOS) late Wednesday was upgraded to Outperform from a previous investment rating of Sector Perform by ...
Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for patients in need, today ...
Following an emotional split from Max Homa, Thomas enlisted the services of his rival's former caddie Joe Greiner, leading to ...
During the event's media day, RBC Canadian Open officials announced that Luke Clanton and Gordon Sargent are expected to make ...
The nearly $100 trillion dollars estimated to pass from older to younger generations by the year 2048* sets up a new era of ...
About INmune Bio Inc. INmune Bio Inc. is a publicly traded (NASDAQ: INMB), clinical-stage biotechnology company focused on developing treatments that target the innate immune system to fight disease.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results